Therapeutic particles
Targeting linacs for new hadron-therapy treatment modes
Isotopes for precision medicine
CERN-MEDICIS has produced its first radioisotopes for medical research
The changing landscape of cancer therapy
Proton and ion therapy set to transform global cancer treatment
Bridging the gap
Working towards medical linacs for challenging environments
Networking against cancer
ENLIGHT: 15 years of promoting hadron therapy in Europe
Strategic step for medical impact
Knowledge transfer has become an established part of CERN’s programme, says Frédérick Bordry.
Novartis acquires CERN spin-off
Global healthcare company Novartis has announced plans to acquire Advanced Accelerator Applications (AAA), a spin-off radiopharmaceutical firm established by former CERN physicist Stefano Buono in 200...
From the web to a start-up near you
The core mission of CERN is fundamental research in particle physics. Yet, as a publicly funded laboratory, it also has a remit to ensure that its technology and expertise deliver prompt and tangible ...
CERN’s recipe for knowledge transfer
We want to build a culture of entrepreneurship whereby more people leaving CERN consider starting a business, says Knowledge Transfer head Giovanni Anelli.
Get on board with EASITrain
Heike Kamerlingh Onnes won his Nobel prize back in 1913 two years after the discovery of superconductivity; Georg Bednorz and Alexander Müller won theirs in 1987, just a year after discovering high-t...
